NSE filing, NSE: AMRUTANJAN. Summary written from the filing by ALFA Finder's alert engine.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹498.35
- Market cap
- ₹1,441 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 26.7×Sector 47.2×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 3.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Q2 FY27 Results: Net Profit ₹17.3 Cr, Up 23.6% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹135.2 Cr (+14.9% YoY) and net profit of ₹17.3 Cr (+23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹17.3 Cr · +23.6% YoY
Amrutanjan Health Care Board Meeting Date
Amrutanjan Health Care scheduled its board meeting for 3 Nov 2026 to consider Q2/H1 results and 1st interim dividend. No financial figures or dividend amount are stated in this advance intimation.
Amrutanjan Health Care Other Announcement
Amrutanjan Health Care received a voluntary CRISIL ESG rating of 'Adequate' (score 60). No capital or operational impact arises from this rating.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend of Rs. 2.90 per share.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend.
- Value
- ₹0.06 Cr
Other dividend announcements
All →Metropolis Healthcare Dividend
Metropolis Healthcare declared an interim dividend of ₹1 per equity share for FY 26-27. The record date is 9 November 2026.
Bayer Cropscience Dividend
Bayer CropScience declared an interim dividend of Rs. 90 per equity share for FY 2026-27 on November 3, 2026. Record date is November 12, 2026 and payment is due November 30, 2026.
BMW Ventures Dividend
BMW Ventures declared an interim dividend of Rs 1.5 per equity share for 2026-27. Record date is 13 November 2026, with payment by 2 December 2026.
Remus Pharmaceuticals Dividend
Remus Pharmaceuticals has fixed 7 November 2026 as the record date for its 1st interim dividend for FY 2026-27, declared at today's board meeting. The filing does not state the per-share dividend amount.
Mobavenue AI Tech Dividend
Mobavenue AI Tech Ltd has declared an interim dividend of ₹0.10 per equity share for FY 2026-27. The company fixed November 13, 2026, as the record date for payment.
TAAL Tech Dividend
TAAL Tech declared an interim dividend of Rs 5 per share for 2026-27. Record date is 13 November 2026 with payment by 2 December.